IL24 and acute promyelocytic leukemia: In addition, we examined increased cytotoxicity in a dose-dependent manner in HL-60 cells (Fig. 3B).[23] These results revealed that AdCN306-IL-24 and AdCN306-EGFP selectively replicate in cancer cells and even AdCN306-IL-24 showed a better efficacy in APL.